The historical rank and industry rank for Neuland Laboratories's Days Inventory or its related term are showing as below:
NSE:NEULANDLAB'
s Days Inventory Range Over the Past 10 Years
Min: 143.65 Med: 159.67 Max: 185.49
Current: 185.49
During the past 13 years, Neuland Laboratories's highest Days Inventory was 185.49. The lowest was 143.65. And the median was 159.67.
NSE:NEULANDLAB's Days Inventory is ranked worse than 58.73% of 916
companies
in the Drug Manufacturers industry
Industry Median: 164.43
vs NSE:NEULANDLAB: 185.49
Neuland Laboratories's Days Inventory
declined
from Mar. 2025 (204.66) to Mar. 2026 (145.05).
Inventory Turnover measures how fast the company turns over its inventory within a year.
Neuland Laboratories's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.63.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Neuland Laboratories's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 0.66.
Neuland Laboratories (NSE:NEULANDLAB) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Neuland Laboratories's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Neuland Laboratories's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Neuland Laboratories Days Inventory Related Terms
Neuland Laboratories Days Inventory Historical Data
* Premium members only.
The historical data trend for Neuland Laboratories's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:NEULANDLAB vs ZTS, UTHR: Days Inventory Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Neuland Laboratories's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Neuland Laboratories Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Neuland Laboratories's Days Inventory distribution charts can be found below:
* The bar in red indicates where Neuland Laboratories's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Neuland Laboratories (NSE:NEULANDLAB) has a Days Inventory of 145.05 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Neuland Laboratories and its competitors. This is near median its historical median of 159.67. Over the past decade, Neuland Laboratories' Days Inventory has ranged from 143.65 to 185.49. According to the industry distribution chart, Neuland Laboratories ranks #538 out of 916 companies in the Drug Manufacturers industry, placing it in the top 58.7%.
Is Neuland Laboratories' Days Inventory too high?
Neuland Laboratories' current Days Inventory of 145.05 is near median its 10-year median of 159.67. Over the past 10 years, this metric has ranged from a low of 143.65 to a high of 185.49. The Drug Manufacturers industry median Days Inventory is 164.43. Neuland Laboratories' value of 145.05 is 11.8% below this industry median. Based on the distribution chart, Neuland Laboratories ranks #538 out of 916 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Neuland Laboratories has a GF Score™ of 90/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Neuland Laboratories' Days Inventory compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Neuland Laboratories ranks #538 out of 916 companies for Days Inventory. This places Neuland Laboratories in the lower half of its industry. The industry median Days Inventory is 164.43. Neuland Laboratories' value of 145.05 is 11.8% below this benchmark. Historically, Neuland Laboratories' own Days Inventory has ranged from 143.65 to 185.49 over the past decade. While the company's 10-year median is 159.67 vs. the industry median of 164.43, Neuland Laboratories has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 164.43, based on 916 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Neuland Laboratories's current Days Inventory of 145.05 is 11.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Neuland Laboratories and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 164.43 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Neuland Laboratories's current Days Inventory is 145.05, which is near median its own 10-year median of 159.67. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Neuland Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Neuland Laboratories (NSE:NEULANDLAB) is currently considered Fairly Valued. The stock's GF Value™ is ₹16,471.48, compared to a current price of ₹18,088.00 — trading 9.8% above its estimated fair value. The current Days Inventory is 145.05, which is near median its 10-year median of 159.67 and 11.8% below the Drug Manufacturers industry median of 164.43. Neuland Laboratories' overall GF Score™ is 90/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Neuland Laboratories (NSE:NEULANDLAB), the current Days Inventory is 145.05 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Neuland Laboratories (NSE:NEULANDLAB) Overvalued in 2026?
Based on GuruFocus' analysis, Neuland Laboratories stock appears to be overvalued.
The current stock price of ₹18,088.00 is trading 9.8% above its estimated GF Value™ of ₹16,471.48.
GuruFocus considers Neuland Laboratories to be Fairly Valued.
Key valuation signals for NSE:NEULANDLAB:
Days Inventory: 145.05 (near median its 10-year median of 159.67)
GF Value™: ₹16,471.48 vs. price of ₹18,088.00 (9.8% above fair value)
Industry Position: 11.8% below the Drug Manufacturers median (#538 of 916)
No single metric tells the full story. See the NSE:NEULANDLAB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Neuland Laboratories Ltd is engaged in the manufacturing and selling of bulk drugs and caters to both the domestic and international markets. It is an API contract development and manufacturing organization (CDMO), supporting biotechnology and pharmaceutical companies in the design, development, and manufacturing of complex active pharmaceutical ingredients (APIs). The company develops small molecules and peptides for clinical trials and beyond, with the capacity to scale up through every stage of the product lifecycle to commercial manufacturing. Geographically, the group derives maximum revenue from its customers in India, followed by Europe, the USA and North America, and the Rest of the world.
90GF Score
Get the complete analysis for NSE:NEULANDLAB
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:NEULANDLAB has been successfully added to your 
